Brevets d'invention - Période du 01/02/2018 au 28/02/2018.
Publication effectuée conformément
| • | à la loi du 20 juillet 1992 portant modification du régime des brevets d’invention (« la loi ») ; |
| • | au règlement (CE) n° 469/2009 du Parlement européen et du Conseil du 6 mai 2009 concernant le certificat complémentaire de protection pour les médicaments (« le règlement (CE) »). |
Remarque :
Les numéros placés entre parenthèses sont les codes d’Identification Numérique Internationalement agréée en matière de Données bibliographiques (INID), recommandés par l’Organisation Mondiale de la Propriété Intellectuelle pour l’identification des données relatives aux brevets d’invention.
Explication des codes INID utilisés :
|
Dans certains cas, il a été nécessaire d’utiliser des codes non fixés par la norme INID. Ces codes sont les suivants :
|
(11) 93164
(22) 04.08.2016
(51) E04H 17/18
(51) E04G 5/00
(51) B65D 19/44
(51) E01F 9/70
(54) Ensemble de rangement et de manutention d'un système de barrières comprenant des panneaux et des plots
(73) IMAGE UP S.À.R.L.
(72) POPP RAZVAN
(72) RIOU CHRISTIAN
(11) 93165
(22) 04.08.2016
(51) B61D 17/10
(54) Sandwichpaneel mit Heizfunktion für Fahrzeuge
(73) EURO-COMPOSITES S.A.
(72) ALTER ROLF-MATHIAS
(72) DOEREN MARC
(72) THIELEN THOMAS
(11) LU100133
(47) 10.01.2018
(22) 03.03.2017
(51) E04F 13/00
(51) F04D 13/16
(51) E04B 1/76
(51) E04F 13/08
(51) E04B 9/00
(51) E04B 9/18
(54) Insulated building structure
(73) Knauf Insulation SPRL
(72) DHEUR Etienne
(31) 1603862.2
(32) 07.03.2016
(33) United Kingdom
(11) LU100341
(47) 30.11.2017
(22) 14.11.2016
(51) A42B
(51) A42B 3/30
(51) A42B 3/12
(54) Fahrradschutzhelm mit einer Rückkamera
(73) ZHANG Ming
(72) ZHANG Ming
(87) 01.06.2017
(31) 2015 2094 7211.6
(32) 25.11.2015
(33) China
(11) LU100439
(47) 04.01.2018
(22) 12.01.2016
(51) B60C 9/00
(51) B60C 15/04
(54) Cablé hybride en fibre de carbone en tant que fil métallique de talon
(73) Kordsa Teknik Tekstil A.S.
(72) FIDAN Saadettin
(72) AKSOY Kursat
(72) GULBEYCAN Neslihan
(87) WO2017/123167
(87) 20.07.2017
(11) LU100450
(47) 04.01.2018
(22) 22.01.2016
(51) D02G 3/48
(54) CABLE EN NYLON 6.6 PEU EXTENSIBLE ET A TENACITE ELEVEE
(73) Kordsa Teknik Tekstil A.S.
(72) FIDAN Saadettin
(72) AKSOY Kursat
(87) WO2017/127032
(87) 27.07.2017
(11) LU100472
(22) 11.10.2017
(51) G06F 9/50
(51) H04L
(54) Data acquisition device based on Cloud Computing
(73) Chengdu Caizhi Shengyou Technology Limited Liability Company
(72) GUO Xin
(31) CN 201710715621.1
(32) 20.08.2017
(33) China
(11) LU100473
(22) 11.10.2017
(51) H04Q 9/00
(51) H04W 4/00
(51) H04B 5/00
(51) H04M 1/00
(54) Data acquisition device based on mobile Internet
(73) Chengdu Caizhi Shengyou Technology Limited Liability Company
(72) GUO Xin
(31) CN 201710715618.X
(32) 20.08.2017
(33) China
(11) LU100474
(22) 11.10.2017
(51) G06F 1/20
(54) Data processing device based on large data technology
(73) Chengdu Caizhi Shengyou Technology Limited Liability Company
(72) GUO Xin
(31) CN 201710715623.0
(32) 20.08.2017
(33) China
(11) LU100475
(22) 11.10.2017
(51) G06F 9/50
(51) H04L
(54) Data analysis device based on Cloud Computing
(73) Chengdu Caizhi Shengyou Technology Limited Liability Company
(72) GUO Xin
(31) CN 201710715624.5
(32) 20.08.2017
(33) China
(11) LU100489
(47) 04.01.2018
(22) 22.10.2015
(51) B60C 9/06
(51) B60C 9/00
(54) CÂBLÉ HYBRIDE EN TANT QUE RENFORT DE CARCASSE DANS DES PNEUS DIAGONAUX
(73) KORDSA GLOBAL ENDUSTRIYEL IPLIK VE KORD BEZI SANAYI VE TICARET ANONIM SIRKETI
(72) FIDAN Mehmet Sadettin
(72) AKSOY Kursat
(87) WO2017/068394
(87) 27.04.2017
(11) 91069
(21) 91069
(22) 07.04.2004
(68) EP0734381
(54) ANTAGONISTES DE RECEPTEURS DES TACHYKININES, A BASE DE MORPHOLINE
(73) MERCK SHARP & DOHME CORP.
(74) DENNEMEYER & ASSOCIATES S.A. PATENT DEPARTMENT
(94) 11.05.2019
(95) APREPITANT et ses sels pharmaceutiquement acceptables (EMEND)
(93) EU/1/03/262/001-006
(93) 11.11.2003
(98) 02.11.2016
(98) Open & Published
(11) 91178
(21) 91178
(22) 22.06.2005
(68) EP0915894
(54) ANALOGUES DE NUCLEOTIDES
(73) GILEAD SCIENCES INC.
(74) OFFICE FREYLINGER S.A.
(94) 21.08.2020
(95) Emtricitabine / Tenofovir Disoproxil et ses dérivés pharmaceutiquement acceptables (TRUVADA®)
(93) EU/1/04/305/001
(93) 21.02.2005
(98) 13.02.2018
(98) Open
(11) 91314
(21) 91314
(22) 21.02.2007
(68) EP1015561
(54) METHODE DE DESASSEMBLAGE-REASSEMBLAGE IN VITRO DE PARTICULES VIROIDES (VLP) DU PAPILLOMAVIRUS
(73) MEDIMMUNE, INC.
(74) OFFICE FREYLINGER S.A.
(94) 20.03.2022
(95) "Combinaison de particules viroides du papillomavirus humain de type 6, 11, 16 et 18"
(93) EU/1/06/357/001-017 - EU/1/06/358/001-017
(93) 20.09.2006
(98) 21.03.2016
(98) Open & Published
(11) 91322
(21) 91322
(22) 08.03.2007
(68) EP0662132
(54) PROTEINES DE CAPSIDES DE VIRUS DU PAPILLOME HPV16 RECOMBINEES A AUTO-ASSEMBLAGE
(73) THE GOVERNMENT OF THE UNITED STATES OF AMERICA DEPARTMENT OF HEALTH AND HUMAN SERVICES
(74) KIRKPATRICK SA / NV
(94) 03.03.2019
(95) "Vaccin Papillomavirus Humain [types 6,11,16,18](recombinant,adsorbé)." - Gardasil
(93) EU/1/06/357/001-017 Gardasil
(93) 20.09.2006
(98) 23.08.2016
(98) Open & Published
(11) 91323
(21) 91323
(22) 08.03.2007
(68) EP0662132
(54) PROTEINES DE CAPSIDES DE VIRUS DU PAPILLOME HPV16 RECOMBINEES A AUTO-ASSEMBLAGE
(73) THE GOVERNMENT OF THE UNITED STATES OF AMERICA DEPARTMENT OF HEALTH AND HUMAN SERVICES
(74) KIRKPATRICK SA / NV
(94) 03.03.2019
(95) "Vaccin Papillomavirus Humain [types 6,11,16,18](recombinant,adsorbé)." - Silgard
(93) EU/1/06/358/001-017 - Silgard
(93) 20.09.2006
(98) 23.08.2016
(98) Open & Published
(11) 91324
(21) 91324
(22) 08.03.2007
(68) EP0662132
(54) PROTEINES DE CAPSIDES DE VIRUS DU PAPILLOME HPV16 RECOMBINEES A AUTO-ASSEMBLAGE
(73) THE GOVERNMENT OF THE UNITED STATES OF AMERICA DEPARTMENT OF HEALTH AND HUMAN SERVICES
(74) KIRKPATRICK SA / NV
(94) 03.03.2019
(95) "Vaccin Papillomavirus Humain [types 6,11,16,18](recombinant,adsorbé)." - Gardasil/Silgard
(93) EU/1/06357/001-017-EU/1/06/358/001-017
(93) 20.09.2006
(98) 23.08.2016
(98) Open & Published
(11) 91437
(21) 91437
(22) 14.05.2008
(68) EP0966454
(54) HETEROCYCLES BICYCLIQUES DISUBSTITUES, PRODUCTION ET UTILISATION COMME MEDICAMENTS
(73) BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG
(74) OFFICE FREYLINGER S.A.
(94) 16.02.2023
(95) "Dabigatran-etexilate et ses sels -particulièrement dabigatran-etexilate-mésilate (PRADAXA®)"
(93) EU/1/08/442/001-008 - PRADAXA / Dabigatran ...
(93) 18.03.2008
(43) 14.07.2008
(11) 92213
(21) 92213
(22) 12.06.2013
(68) EP2107069
(54) Nouveaux dérivés d'insuline
(73) NOVO NORDISK A/S
(74) OFFICE FREYLINGER S.A.
(94) 21.07.2028
(95) "Insuline dégludec sous toutes les formes protégées par le brevet de base"
(93) EU/1/12/807/001-4-5-7-8-9-12-13-15 Tresiba
(93) 21.01.2013
(98) 14.12.2016
(98) Open & Published
(11) LUC00044
(21) LUC00044
(22) 25.10.2017
(68) EP2371392
(54) Conjugués de type vecteur-dérivé de calichéamicine
(73) WYETH HOLDINGS LLC
(74) Office FREYLINGER S.A.
(92) EU/1/17/1200
(92) 03.07.2017
(94) 02.05.2028
(95) Inotuzumab ozogamicine et ses dérivés pharmaceutiquement acceptables (BESPONSA®)
(43) 03.11.2017
(11) LUC00045
(21) LUC00045
(22) 26.10.2017
(68) EP2464382
(54) THÉRAPIE COMBINÉE D'UN ANTICORPS CD20 AFUCOSYLATÉ ET DE BENDAMUSTINE
(73) Roche Glycart AG
(74) Office FREYLINGER S.A.
(92) EU/1/14/937
(92) 15.06.2016
(94) 15.06.2031
(95) Obinutuzumab associé à la bendamustine
(43) 03.11.2017
(11) LUC00051
(21) LUC00051
(22) 29.11.2017
(68) EP2376535
(54) ANTICORPS ANTI-PD-L1 ET LEUR UTILISATION POUR AMÉLIORER LA FONCTION DES LYMPHOCYTES T
(73) F. Hoffmann-La Roche AG
(74) OFFICE FREYLINGER S.A.
(92) EU/1/17/1220
(92) 25.09.2017
(94) 25.09.2032
(95) "Atezolizumab"
(43) 30.11.2017
(11) LUC00052
(21) LUC00052
(22) 30.11.2017
(68) EP1210428
(54) PD-1, RECEPTEUR DE B7-4, ET SON UTILISATION
(73) Dana-Farber Cancer Institute Inc.
(73) Genetics Institute LLC
(74) PRONOVEM LUXEMBOURG S.A.
(92) EU/1/17/1214
(92) 20.09.2017
(94) 23.08.2025
(95) Avélumab
(43) 30.11.2017
(11) LUC00053
(21) LUC00053
(22) 04.12.2017
(68) EP2567976
(54) Anticorps diriges contre CD38 pour le traitement du myelome multiple
(73) Genmab A/S
(74) OFFICE FREYLINGER S.A.
(92) EU/1/16/1101
(92) 24.05.2016
(94) 23.03.2031
(95) "Anticorps de liaison à la CD38 humaine, comprenant des séquences CDR variables de chîne légère humaine et de chîane lourde humaine selon la revendication 1 du brevet EP2567976 (SEQ ID Num 13,14,15,18,19 et 20) ; particulièrement un anticorps comprenant les régions variables de chîne lourde et légère selon les revendications 8 et 10 du brevet EP2567976 (SEQ ID Num 17 et 12) ; particulièrement un anticorps comprenant les régions variables de chaîne lourde et légère selon les revendications 8 et 10 du brevet EP2567976 (SEQ ID NUm 17 et 12), et qui est un anticorps monoclonal humain IgG1,k; et spécifiquement le daratumumab."
(43) 07.12.2017
(11) LUC00054
(21) LUC00054
(22) 11.12.2017
(68) EP2316456
(54) Compositions comprenant un antagoniste des opioides et bupropion pour influencer la perte de poids
(73) Orexigen Therapeutics, Inc.
(74) DENNEMEYER & ASSOCIATES S.A. PATENT DEPARTMENT
(92) EU/1/14/988
(92) 30.03.2015
(94) 21.04.2029
(95) Naltrexone or a pharmaceutically acceptable salt thereof, in particular naltrexone hydrochloride, and bupropion or a pharmaceutically acceptable salt thereof, in particular bupropion hydrochloride
(43) 13.12.2017
(11) LUC00055
(21) LUC00055
(22) 12.12.2017
(68) EP1638574
(54) NOUVELLE UTILISATION DE DERIVES DE STAUROSPORINE
(73) Novartis AG
(73) Novartis Pharma GmbH
(74) OFFICE FREYLINGER S.A.
(92) EU/1/17/1218
(92) 20.09.2017
(94) 17.06.2029
(95) "Midostaurine ou un sel de celle-ci"
(43) 14.12.2017
(11) LUC00056
(21) LUC00056
(22) 15.12.2017
(68) EP2076541
(54) PROTÉINES DE LIAISON À L'ANTIGÈNE DU RÉCEPTEUR A DE L'IL-17
(73) Kirin-Amgen Inc.
(74) DENNEMEYER & ASSOCIATES S.A. PATENT DEPARTMENT
(92) EU/1/16/1155/001-002
(92) 19.07.2017
(94) 19.07.2032
(95) An isolated antibody or fragment thereof comprising light chain and heavy chain CDR sequences according to EP-B1-2076541 claim 1 (SEQ ID NOs: 224,225,226 and 146, 147, 148), wherein the antibody or fragment thereof binds human IL-17 receptor A; especially an antibody comprising the light and heavy chain variable region sequences according to EP-B1-2076541 claim 2 (SEQ ID NOs: 40 and 14), such as an IgG2 antibody comprising the light and heavy chain variable region sequences according to EP-B1-2076541 claim 2 (SEQ ID NOs: 40 and 14); and specifically brodalumab; and its derivates protected by EP-B1-2076541.
(43) 20.12.2017
(11) LUC00057
(21) LUC00057
(22) 21.12.2017
(68) EP1504035
(54) ANTICORPS SPECIFIQUES A L' HUMAIN CD22 ET LEURS UTILISATION THERAPEUTIQUES ET DIAGNOSTIQUES
(73) UCB Pharma, S.A.
(74) DENNEMEYER & ASSOCIATES S.A. PATENT DEPARTMENT
(92) EU/1/17/1200/001
(92) 03.07.2017
(94) 02.05.2028
(95) Antibody molecule having specificity for human CD22 comprising light and heavy chain variable domain complementarity determining region (CDR) sequences according to claim 1 of the basic patent, such as an antibody molecule comprising the light and heavy chain variable region sequences according to claim 10 of the basic patent, in particular an antibody molecule comprising inotuzumab; wherein the antibody molecule is covalently linked to a toxin, in particular ozogamicin; such as inotuzumab ozogamicin, or a derivative or variant thereof protected by the basic patent
(43) 27.12.2017
(11) LUC00058
(21) LUC00058
(22) 21.12.2017
(68) EP1504035
(54) ANTICORPS SPECIFIQUES A L' HUMAIN CD22 ET LEURS UTILISATION THERAPEUTIQUES ET DIAGNOSTIQUES
(73) UCB Pharma, S.A.
(74) DENNEMEYER & ASSOCIATES S.A. PATENT DEPARTMENT
(92) EU/1/17/1200/001
(92) 03.07.2017
(94) 02.05.2028
(95) Antibody molecule having specificity for human CD22 comprising light and heavy chain variable domain complementarity determining region (CDR) sequences according to claim 1 of the basic patent, such as an antibody molecule comprising the light and heavy chain variable region sequences according to claim 10 of the basic patent, in particular an antibody molecule comprising inotuzumab, or a derivative or variant thereof protected by the basic patent
(43) 27.12.2017
(11) LUC00062
(21) LUC00062
(22) 02.02.2018
(68) EP2865422
(54) Dérivés de la MSH-Alpha pour le traitement de photodermatoses
(74) Office FREYLINGER S.A.
(92) EU/1/14/969
(92) 29.12.2014
(94) 29.12.2029
(95) Afamélanotide et ses dérivés pharmaceutiquement acceptables (Scenesse)
(11) LUC00063
(21) LUC00063
(22) 06.02.2018
(68) EP2099453
(54) Thérapie combinatoire à base d'oxazolidinone substituée
(74) PRONOVEM LUXEMBOURG S.A.
(92) C(2013)3109
(92) 24.05.2013
(94) 24.05.2028
(95) Rivaroxaban en combinaison avec l'acide acétylsalicylique et le clopidogrel
(11) LUC00064
(21) LUC00064
(22) 12.02.2018
(68) EP2805723
(54) Régime posologique de cladribine pour le traitement de la sclérose en plaques
(74) Office FREYLINGER S.A.
(92) EU/1/17/1212
(92) 24.08.2017
(94) 20.12.2030
(95) Cladribine
(11) LUC00065
(21) LUC00065
(22) 12.02.2018
(68) EP1608344
(54) FORMULATIONS DE LA CLADRIBINE A ADMINISTRATION PAR VOIE ORALE
(74) Office FREYLINGER S.A.
(92) EU/1/17/1212
(92) 24.08.2017
(94) 26.03.2029
(95) Cladribine
(11) EP1958327
(21) EP1958327
(51) H03D 7/14
(51) H03F 3/193
(51) H03F 3/45
(11) EP2405651
(21) EP2405651
(51) H04N 7/16
(51) H04N 7/167
(51) H04N 21/61
(51) H04N 21/266
(11) EP2764262
(21) EP2764262
(51) F16C 33/02
(51) F16C 33/10
(11) EP1140157
(DE) 20.12.2017
(Rn) European Patent got Revoked
(11) EP1505973
(DE) 28.11.2017
(Rn) European Patent got Revoked
(11) EP1747995
(DE) 28.11.2017
(Rn) European Patent got Revoked
(11) EP1925308
(DE) 05.10.2017
(Rn) European Patent got Revoked
(11) EP2234091
(DE) 26.09.2017
(Rn) European Patent got Revoked
(11) EP2404600
(DE) 29.10.2017
(Rn) European Patent got Revoked
(11) EP2719689
(DE) 29.09.2017
(Rn) European Patent got Revoked
(11) EP2864027
(DE) 16.10.2017
(Rn) European Patent got Revoked
(11) 91280
(21) 91280
(73) BAYER HEALTHCARE LLC
(R) 22.02.2018
(TC) Change of owner(s) name
(11) 92364
(21) 92364
(73) Elanco US Inc.
(R) 14.02.2018
(TC) Change of ownership
(11) EP0968706
(21) EP0968706
(73) Elanco US Inc.
(R) 14.02.2018
(51) A61K 8/49
(TC) Change of ownership
(11) EP1140840
(21) EP1140840
(73) BAYER HEALTHCARE LLC
(R) 22.02.2018
(51) C07D 211/78
(TC) Change of owner(s) name
(11) EP1197207
(21) EP1197207
(73) Elanco US Inc.
(R) 14.02.2018
(51) A61K 9/16
(TC) Change of ownership
(11) EP1303509
(21) EP1303509
(73) Elanco US Inc.
(R) 14.02.2018
(51) C07D 409/12
(TC) Change of ownership
(11) EP1435780
(21) EP1435780
(73) Elanco US Inc.
(R) 14.02.2018
(51) A01N 43/22
(TC) Change of ownership
(11) EP1435786
(21) EP1435786
(73) Elanco US Inc.
(R) 14.02.2018
(51) A01N 45/02
(TC) Change of ownership
(11) EP1662987
(21) EP1662987
(73) Theranos IP Company, LLC
(R) 07.02.2018
(51) A61B 5/00
(TC) Change of ownership
(11) EP1690853
(21) EP1690853
(73) BAYER HEALTHCARE LLC
(R) 22.02.2018
(51) A61K 31/17
(51) A61K 31/33
(51) A61K 31/535
(51) A61K 31/54
(51) C07C 275/20
(51) C07C 275/22
(51) C07C 275/24
(51) C07C 275/28
(51) C07D 211/72
(51) C07D 211/78
(TC) Change of owner(s) name
(11) EP1735475
(21) EP1735475
(73) SHOWA DENKO CARBON Germany GmbH
(R) 20.02.2018
(51) C22B 7/02
(TC) Change of ownership
(11) EP1735496
(21) EP1735496
(73) GPCP IP Holdings LLC
(R) 20.02.2018
(51) D21F 11/02
(TC) Change of ownership
(11) EP1744763
(21) EP1744763
(73) Elanco US Inc.
(R) 14.02.2018
(51) A61K 31/7048
(TC) Change of ownership
(11) EP1751625
(21) EP1751625
(73) AGFA NV
(R) 13.02.2018
(51) G03F 7/32
(TC) Change of owner(s) name
(11) EP1756359
(21) EP1756359
(73) GPCP IP Holdings LLC
(R) 20.02.2018
(51) D21F 11/14
(TC) Change of ownership
(11) EP1761671
(21) EP1761671
(73) GPCP IP Holdings LLC
(R) 20.02.2018
(51) D21F 11/00
(TC) Change of ownership
(11) EP1841699
(21) EP1841699
(73) SHOWA DENKO CARBON Germany GmbH
(R) 20.02.2018
(51) C03B 5/00
(TC) Change of ownership
(11) EP1872351
(21) EP1872351
(73) Neology, Inc.
(R) 13.02.2018
(51) G08G 1/054
(TC) Change of ownership
(11) EP1878314
(21) EP1878314
(73) SHOWA DENKO CARBON Germany GmbH
(R) 20.02.2018
(51) H05B 7/14
(TC) Change of ownership
(11) EP1879736
(21) EP1879736
(73) GPCP IP Holdings LLC
(R) 20.02.2018
(51) B31F 1/12
(TC) Change of ownership
(11) EP1951296
(21) EP1951296
(73) Seqirus UK Limited
(R) 14.02.2018
(51) A61K 39/13
(TC) Change of ownership
(11) EP1960556
(21) EP1960556
(73) SHOWA DENKO CARBON Germany GmbH
(R) 20.02.2018
(51) C21B 3/04
(TC) Change of ownership
(11) EP1973561
(21) EP1973561
(73) Elanco US Inc.
(R) 14.02.2018
(51) A61K 38/43
(TC) Change of ownership
(11) EP1985754
(21) EP1985754
(73) GPCP IP Holdings LLC
(R) 20.02.2018
(51) D21H 25/00
(TC) Change of ownership
(11) EP1986633
(21) EP1986633
(73) Summit Therapeutics plc
(R) 01.02.2018
(51) A61K 31/343
(TC) Change of owner(s) name
(11) EP1986633
(21) EP1986633
(73) Summit (Oxford) Limited
(R) 01.02.2018
(51) A61K 31/343
(TC) Change of ownership
(11) EP1998750
(21) EP1998750
(73) ONXEO
(R) 01.02.2018
(51) A61K 9/22
(TC) Change of owner(s) name
(11) EP2001662
(21) EP2001662
(73) GPCP IP Holdings LLC
(R) 20.02.2018
(51) B31F 1/12
(TC) Change of ownership
(11) EP2018188
(21) EP2018188
(73) Theranos IP Company, LLC
(R) 07.02.2018
(51) C12Q 1/70
(TC) Change of ownership
(11) EP2035119
(21) EP2035119
(73) SHOWA DENKO CARBON Germany GmbH
(R) 20.02.2018
(51) B01D 53/62
(TC) Change of ownership
(11) EP2035220
(21) EP2035220
(73) GPCP IP Holdings LLC
(R) 20.02.2018
(51) D21H 17/24
(TC) Change of ownership
(11) EP2074259
(21) EP2074259
(73) GPCP IP Holdings LLC
(R) 20.02.2018
(51) D21H 17/43
(TC) Change of ownership
(11) EP2077069
(21) EP2077069
(73) Bijl Beheer B.V.
(R) 24.01.2018
(51) A01G 23/06
(TC) Change of ownership
(11) EP2079954
(21) EP2079954
(73) Khansaheb Industries Owned by Khansaheb Investment One Person CO LLC
(R) 09.02.2018
(51) F16L 9/17
(TC) Change of ownership
(11) EP2111468
(21) EP2111468
(73) SHOWA DENKO CARBON Germany GmbH
(R) 20.02.2018
(51) C22B 5/10
(TC) Change of ownership
(11) EP2178851
(21) EP2178851
(73) Elanco US Inc.
(R) 14.02.2018
(51) C07D 261/08
(TC) Change of ownership
(11) EP2222315
(21) EP2222315
(73) Cangene Corporation
(R) 14.02.2018
(51) A61K 35/14
(TC) Change of ownership
(11) EP2222315
(21) EP2222315
(73) 407850 Manitoba Partnership
(R) 14.02.2018
(51) A61K 35/14
(TC) Change of ownership
(11) EP2222315
(21) EP2222315
(73) Aptevo BioTherapeutics LLC
(R) 14.02.2018
(51) A61K 35/14
(TC) Change of ownership
(11) EP2241891
(21) EP2241891
(73) INSERM - Institut National de la Santé et de la Recherche Médicale
(73) Assistance Publique - Hôpitaux de Paris (AP-HP)
(73) Université Paris Descartes
(R) 07.02.2018
(51) G01N 33/574
(TC) Change of ownership
(11) EP2255139
(21) EP2255139
(73) SHOWA DENKO CARBON Germany GmbH
(R) 20.02.2018
(51) F27B 1/08
(TC) Change of ownership
(11) EP2297577
(21) EP2297577
(73) Elanco US Inc.
(R) 14.02.2018
(51) A22C 17/10
(51) G01N 33/53
(TC) Change of ownership
(11) EP2330250
(21) EP2330250
(73) GPCP IP Holdings LLC
(R) 20.02.2018
(51) D21H 17/36
(TC) Change of ownership
(11) EP2337874
(21) EP2337874
(73) H.C. Starck Surface Technology and Ceramic Powders GmbH
(R) 09.02.2018
(51) C22C 29/00
(TC) Change of ownership
(11) EP2342223
(21) EP2342223
(73) Ambrx, Inc.
(73) Elanco US Inc.
(R) 14.02.2018
(51) C07K 14/505
(51) C12N 15/11
(51) C12N 15/16
(51) C12N 5/10
(51) C12P 21/02
(51) A61P 7/06
(TC) Change of ownership
(11) EP2373631
(21) EP2373631
(73) Summit (Oxford) Limited
(R) 01.02.2018
(51) C07D 235/18
(TC) Change of ownership
(11) EP2391504
(21) EP2391504
(73) GPCP IP Holdings LLC
(R) 20.02.2018
(51) B31F 1/07
(TC) Change of ownership
(11) EP2420835
(21) EP2420835
(73) INSERM - Institut National de la Santé et de la Recherche Médicale
(73) Assistance Publique - Hôpitaux de Paris (AP-HP)
(73) Université Paris Descartes
(R) 07.02.2018
(51) G01N 33/574
(TC) Change of ownership
(11) EP2420836
(21) EP2420836
(73) INSERM - Institut National de la Santé et de la Recherche Médicale
(73) Assistance Publique - Hôpitaux de Paris (AP-HP)
(73) Université Paris Descartes
(R) 07.02.2018
(51) G01N 33/574
(TC) Change of ownership
(11) EP2420837
(21) EP2420837
(73) INSERM - Institut National de la Santé et de la Recherche Médicale
(73) Assistance Publique - Hôpitaux de Paris (AP-HP)
(73) Université Paris Descartes
(R) 07.02.2018
(51) G01N 33/574
(TC) Change of ownership
(11) EP2420838
(21) EP2420838
(73) INSERM - Institut National de la Santé et de la Recherche Médicale
(73) Assistance Publique - Hôpitaux de Paris (AP-HP)
(73) Université Paris Descartes
(R) 07.02.2018
(51) G01N 33/574
(TC) Change of ownership
(11) EP2420839
(21) EP2420839
(73) INSERM - Institut National de la Santé et de la Recherche Médicale
(73) Assistance Publique - Hôpitaux de Paris (AP-HP)
(73) Université Paris Descartes
(R) 07.02.2018
(51) G01N 33/574
(TC) Change of ownership
(11) EP2420840
(21) EP2420840
(73) INSERM - Institut National de la Santé et de la Recherche Médicale
(73) Assistance Publique - Hôpitaux de Paris (AP-HP)
(73) Université Paris Descartes
(R) 07.02.2018
(51) G01N 33/574
(TC) Change of ownership
(11) EP2440177
(21) EP2440177
(73) AbbVie Deutschland GmbH & Co. KG
(R) 31.01.2018
(51) A61K 9/00
(TC) Change of ownership
(11) EP2492393
(21) EP2492393
(73) GPCP IP Holdings LLC
(R) 20.02.2018
(51) D21F 11/02
(TC) Change of ownership
(11) EP2506978
(21) EP2506978
(73) Exner-Geiger Technology GmbH & Co. KG
(R) 31.01.2018
(51) B03C 1/247
(TC) Change of ownership
(11) EP2527480
(21) EP2527480
(73) H.C. Starck Surface Technology and Ceramic Powders GmbH
(R) 09.02.2018
(51) C22C 29/00
(51) C22C 29/06
(TC) Change of ownership
(11) EP2528587
(21) EP2528587
(73) Elanco US Inc.
(R) 14.02.2018
(51) A61K 31/7048
(TC) Change of ownership
(11) EP2563771
(21) EP2563771
(73) Viamet Pharmaceuticals (NC), Inc.
(R) 16.02.2018
(51) C07D 401/06
(TC) Change of owner(s) name
(11) EP2575968
(21) EP2575968
(73) Summit (Oxford) Limited
(R) 01.02.2018
(51) A61K 38/14
(TC) Change of ownership
(11) EP2607549
(21) EP2607549
(73) GPCP IP Holdings LLC
(R) 20.02.2018
(51) D21F 11/00
(TC) Change of ownership
(11) EP2610051
(21) EP2610051
(73) GPCP IP Holdings LLC
(R) 20.02.2018
(51) D21F 11/00
(TC) Change of ownership
(11) EP2618830
(21) EP2618830
(73) Elanco US Inc.
(R) 14.02.2018
(51) A61K 38/19
(TC) Change of ownership
(11) EP2633991
(21) EP2633991
(73) GPCP IP Holdings LLC
(R) 20.02.2018
(51) B31F 1/07
(TC) Change of ownership
(11) EP2710000
(21) EP2710000
(73) Elanco US Inc.
(R) 14.02.2018
(51) C07D 413/04
(TC) Change of ownership
(11) EP2733493
(21) EP2733493
(73) INSERM - Institut National de la Santé et de la Recherche Médicale
(73) Assistance Publique - Hôpitaux de Paris (AP-HP)
(73) Université Paris Descartes
(R) 07.02.2018
(51) G01N 33/574
(TC) Change of ownership
(11) EP2792790
(21) EP2792790
(73) GPCP IP Holdings LLC
(R) 20.02.2018
(51) D21H 17/24
(TC) Change of ownership
(11) EP2830644
(21) EP2830644
(73) Stealth Bio Therapeutics Corp
(R) 14.02.2018
(51) A61K 38/08
(TC) Change of owner(s) name
(11) EP2858318
(21) EP2858318
(73) NEX Services North America LLC
(R) 14.02.2018
(51) H04L 12/863
(TC) Change of owner(s) name
(11) EP2907813
(21) EP2907813
(73) Summit (Oxford) Limited
(R) 01.02.2018
(51) C07D 235/18
(TC) Change of ownership
(11) EP2912021
(21) EP2912021
(73) Elanco US Inc.
(R) 14.02.2018
(51) C07D 233/76
(51) A61K 31/4166
(TC) Change of ownership
(11) EP2946765
(21) EP2946765
(73) Fresenius Kabi Deutschland GmbH
(R) 01.02.2018
(51) A61K 9/19
(TC) Change of ownership
(11) EP2970424
(21) EP2970424
(73) Elanco US Inc.
(73) Ambrx, Inc.
(R) 14.02.2018
(51) C07K 14/575
(TC) Change of ownership